66
Participants
Start Date
April 30, 2005
Primary Completion Date
December 31, 2006
Study Completion Date
July 31, 2008
Nanoparticle albumin bound paclitaxel followed by FEC
Nanoparticle albumin bound paclitaxel 100 mg/m2 IV for 30 minutes once weekly for 12 weeks followed by FEC (5-FU 500mg/m2 IV push; epirubicin 100 mg/m2 IV over 15 min. \[or if given with trastuzumab 75 mg/m2 IV over 15 min.\]; cyclophosphamide 500 mg/m2 IV over 30 min.) on Day 1 every 21 days
NSABP Operations Center, Pittsburgh
Collaborators (1)
Celgene Corporation
INDUSTRY
NSABP Foundation Inc
NETWORK